Down-regulation of Cdc25c, CDK1 and cyclin B1 and up-regulation of Wee1 by curcumin promotes human colon cancer colo 205 cell entry into G2/M-phase of cell cycle

Cancer Genomics and Proteomics

Volumn 3, Issue 1, 2006, Pages 55-61

  Su, Chin Cheng ^a   Lin, Jaung Geng ^a   Chen, Guang Wei ^a   Lin, Wen Chuan ^a   Chung, Jing Gung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cdc25c; CDK1; Cell cycle arrest; Curcumin; Cyclin B1; Wee1

Indexed keywords

COMPLEMENTARY DNA; CURCUMIN; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYTOTOXIC AGENT; MESSENGER RNA;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG CYTOTOXICITY; FLOW CYTOMETRY; GENE; GENE WEE1; HUMAN; HUMAN CELL; UPREGULATION; WESTERN BLOTTING;

EID: 33144487904     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Farhana L, Dawson M, Rishi AK, Zhang Y, Van Buren E, Trivedi C, Reichert U, Fang G, Kirschner MW and Fontana JA: Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway. Cancer Res 62: 3842-3849, 2002.
2. Freya W, Bora A, Antje C and Jurgen S: Down-regulation of the cyclin D1/cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 131: 2197-2203, 2001.
3. Joe AK, Liu H, Suzui M, Vural M, Xiao D and Weinstein B: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8: 893-903, 2002.
4. Hartwell LH and Kastan MB: Cell cycle control and cancer. Science 266: 1821-1823, 1994.
5. Sherr CJ: Cancer cell cycle. Science 274: 1672-1677, 1996.
6. Gong J, Traganos F and Darzynkiewicz Z: Threshold expression of cyclin E but not D type cyclins characterizes normal and tumor cells entering S phase. Cell Prolif 28: 337-346, 1995.
7. Muschel RJ, Zhang HB, Iliakis G and McKenna WG: Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res 51: 5113-5137, 1991.
8. Metting NF and Little JB: Transient failure to dephosphorylate the cdc2-cyclin B1 complex accompanies tradition-induced G2-phase arrest in HeLa cells. Radiat Res 143: 286-292, 1995.
9. Kao GD, McKenna WG, Maity A, Blank K and Muschel RJ: Cyclin B1 availability is a rate-limiting component of the radiation-induced G2 delay in HeLa cells. Cancer Res 57: 753-758, 1997.
10. Azzam EI, de Toledo SM, Gooding T and Little JB: Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluency of alpha particles. Radiat Res 150: 497-504, 1998.
11. Baeuerle PA and Baltimore D: NF-kappa B: ten years after. Cell 87: 13-20, 1996.
12. Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D, Ogi J, Khaletskiy A, Li Z and Li JJ: Manganese super oxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 23: 2362-2378, 2003.
13. Ammon HP and Wahl MA: Pharmacology of Curcuma longa. Plant Med 57: 1-7, 1991.
14. Kuo ML, Huang TS and Lin JK: Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochem Biophys Acta 1317: 95-100, 1996.
15. Chen H, Zhang ZS, Zhang YL and Zhou DY: Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 19: 3675-3680, 1999.
16. Mehta K, Pantazis P, McQueen T and Aggarwal BB: Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8: 470-481, 1997.
17. Huang M-T, Ma W, Lu Y-P, Chang RL, Fisher C, Manchand PS, Newmark HL and Conney AH: Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16: 2493-2497, 1995.
18. Rao CV, Rivenson A, Simi B and Reddy BS: Chemoprevention by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55: 259-266, 1995.
19. Huang M-T, Lysz T, Ferraro T, Abidi TF, Laskin JD and Conney AH: Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51: 813-819, 1991.
20. Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC and Chung JG: Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res 25: 971-979, 2005.
21. Chen HC, Hsieh WT, Chang WC and Chung JG: Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 42: 1251-1257, 2004.
22. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
23. Chen JC, Hwang JM, Chen GW, Hsia TC and Chung JG: Curcumin decreases the DNA adduct formation, arylamines N-acetyltransferase activity and gene expression in human colon tumor cells (colo 205). In Vivo 17: 301-309, 2003.
24. Tathagata Choudhuri, Suman Pal, Tanya Das and Gaurisankar Sa: Curcumin selectively induces apoptosis in deregulated cyclin D1 expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280: 20059-20068, 2005.
25. Moragoda L, Jaszewski R and Majumdar AP: Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res 21: 873-878, 2001.
26. Chen H, Zhang ZS, Zhang YL and Zhou DY: Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 19: 3675-3680, 1999.